Specialty Generics - Global Market Outlook (2016-2022)                 

Specialty Generics - Global Market Outlook (2016-2022)                 

  • Published: February 2017
  • ID: SMRC16342

According to Stratistics MRC, the Global Specialty Generics market is estimated at $XX billion in 2016 and is expected to reach $XX billion by 2022 growing at a CAGR of XX% from 2016 to 2022. Increase in prevalence of cancer across the globe and favourable government policies are the factors fuelling the market growth. Whereas factors like lack of skilled professionals is restraining the market. Oncology segment is anticipated to grow at higher CAGR during forecast period owing to the expirations of existing patent. North America accounted for the highest market share as compared to other regions owing to favourable government policies. Asia pacific region is expected to show healthy growth rate during forecast period.

Some of the key players in the market include Valeant Pharmaceuticals International, Inc., Novartis, Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd., Mylan N.V., Akorn, Inc., Mallinckrodt, Intellipharmaceutics and Alvogen.

Route of Administration Covered:
• Topical
• Parenteral
• Oral
• Other Route of Administration

Disease Indications Covered:
• Multiple Sclerosis
• Infectious diseases
• Oncology
• Other Disease Indications

Distribution Channels Covered:
• Mail Order Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary 
  
2 Preface
 
 2.1 Abstract
 2.2 Stake Holders
 2.3 Research Scope
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
  
3 Market Trend Analysis 
 3.1 Introduction
 3.2 Drivers
 3.3 Restraints
 3.4 Opportunities
 3.5 Threats
 3.6 Emerging Markets
 3.7 Futuristic Market Scenario
  
4 Porters Five Force Analysis 
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry
  
5 Global Specialty Generics Market, By Route of Administration 
 5.1 Introduction
 5.2 Topical
 5.3 Parenteral
 5.4 Oral
 5.5 Other Route of Administration
  
6 Global Specialty Generics Market, By Disease Indication 
 6.1 Introduction
 6.2 Multiple Sclerosis
 6.3 Infectious diseases
 6.4 Oncology
 6.5 Other Disease Indications
  
7 Global Specialty Generics Market, By Distribution Channel 
 7.1 Introduction
 7.2 Mail Order Pharmacies
 7.3 Hospital Pharmacies
 7.4 Retail Pharmacies
  
8 Global Specialty Generics Market, By Geography 
 8.1 North America
  8.1.1 US
  8.1.2 Canada
  8.1.3 Mexico
 8.2 Europe
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
  8.2.6 Rest of Europe
 8.3 Asia Pacific
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.6 Rest of Asia Pacific
 8.4 Rest of the World
  8.4.1 Middle East
  8.4.2 Brazil
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt
  
9 Key Developments 

 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers
 9.3 New Product Launch
 9.4 Expansions
 9.5 Other Key Strategies
  
10 Company Profiling 
 10.1 Valeant Pharmaceuticals International, Inc.
 10.2 Novartis
 10.3 Pfizer Inc.
 10.4 Turing Pharmaceuticals
 10.5 Teva Pharmaceutical Ltd.
 10.6 Mylan N.V.
 10.7 Akorn, Inc.
 10.8 Mallinckrodt
 10.9 Intellipharmaceutics
 10.10 Alvogen


List of Tables  
1 Global Specialty Generics Market Outlook, By Region (2014-2022) ($MN) 
2 Global Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN) 
3 Global Specialty Generics Market Outlook, By Topical (2014-2022) ($MN) 
4 Global Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN) 
5 Global Specialty Generics Market Outlook, By Oral (2014-2022) ($MN) 
6 Global Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN) 
7 Global Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN) 
8 Global Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN) 
9 Global Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN) 
10 Global Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN) 
11 Global Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN) 
12 Global Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN) 
13 Global Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN) 
14 Global Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN) 
15 Global Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN) 
16 North America Specialty Generics Market Outlook, By Country (2014-2022) ($MN) 
17 North America Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN) 
18 North America Specialty Generics Market Outlook, By Topical (2014-2022) ($MN) 
19 North America Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN) 
20 North America Specialty Generics Market Outlook, By Oral (2014-2022) ($MN) 
21 North America Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN) 
22 North America Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN) 
23 North America Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN) 
24 North America Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN) 
25 North America Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN) 
26 North America Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN) 
27 North America Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN) 
28 North America Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN) 
29 North America Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN) 
30 North America Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN) 
31 Europe Specialty Generics Market Outlook, By Country (2014-2022) ($MN) 
32 Europe Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN) 
33 Europe Specialty Generics Market Outlook, By Topical (2014-2022) ($MN) 
34 Europe Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN) 
35 Europe Specialty Generics Market Outlook, By Oral (2014-2022) ($MN) 
36 Europe Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN) 
37 Europe Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN) 
38 Europe Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN) 
39 Europe Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN) 
40 Europe Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN) 
41 Europe Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN) 
42 Europe Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN) 
43 Europe Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN) 
44 Europe Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN) 
45 Europe Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN) 
46 Asia Pacific Specialty Generics Market Outlook, By Country (2014-2022) ($MN) 
47 Asia Pacific Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN) 
48 Asia Pacific Specialty Generics Market Outlook, By Topical (2014-2022) ($MN) 
49 Asia Pacific Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN) 
50 Asia Pacific Specialty Generics Market Outlook, By Oral (2014-2022) ($MN) 
51 Asia Pacific Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN) 
52 Asia Pacific Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN) 
53 Asia Pacific Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN) 
54 Asia Pacific Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN) 
55 Asia Pacific Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN) 
56 Asia Pacific Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN) 
57 Asia Pacific Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN) 
58 Asia Pacific Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN) 
59 Asia Pacific Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN) 
60 Asia Pacific Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN) 
61 RoW Specialty Generics Market Outlook, By Country (2014-2022) ($MN) 
62 RoW Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN) 
63 RoW Specialty Generics Market Outlook, By Topical (2014-2022) ($MN) 
64 RoW Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN) 
65 RoW Specialty Generics Market Outlook, By Oral (2014-2022) ($MN) 
66 RoW Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN) 
67 RoW Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN) 
68 RoW Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN) 
69 RoW Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN) 
70 RoW Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN) 
71 RoW Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN) 
72 RoW Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN) 
73 RoW Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN) 
74 RoW Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN) 
75 RoW Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN)  

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials